Product category
Hospital Injectable Products
33 public development records. Search this category and review proposed presentations, evidence limits and attributed references.
- Records
- 33
- Medicines
- 33
- Devices / diagnostics
- 0
- Presentations represented
- 2
Public development records
Hospital Injectable Products records
Category placement supports navigation. It does not establish an approved indication, suitability for a particular patient group, prescription status or eligibility for supply.
Showing 33 of 33 records
Portfolio records
| Record | Dosage form / type | Proposed strength / configuration | Proposed pack | Status |
|---|---|---|---|---|
| Adrenaline InjectionLP-174 | InjectionMedicine | 1 mg/mL | Ampoule 1 mL; carton 10 ampoules | Development record |
| Ampicillin Powder for injectionLP-175 | Powder for injectionMedicine | 500 mg vial; 1 g vial | Vial; carton 10 vials | Development record |
| Atropine InjectionLP-176 | InjectionMedicine | 0.6 mg/mL | Ampoule 1 mL; carton 10 ampoules | Development record |
| Benzathine benzylpenicillin Powder for injectionLP-177 | Powder for injectionMedicine | 1.2 million IU vial; 2.4 million IU vial | Vial; carton 10 vials | Development record |
| Calcium folinate InjectionLP-178 | InjectionMedicine | 10 mg/mL ready-to-use solution; 50 mg per 5 mL vial (10 mg/mL) ready-to-use | Vial/ampoule; carton 10 | Development record |
| Cefazolin Powder for injectionLP-179 | Powder for injectionMedicine | 1 g vial; 2 g vial | Vial; carton 10 vials | Development record |
| Ceftriaxone Powder for injectionLP-180 | Powder for injectionMedicine | 500 mg vial; 1 g vial; 2 g vial | Vial; carton 10 vials | Development record |
| Cyanocobalamin (Vitamin B12) InjectionLP-181 | InjectionMedicine | 1000 mcg/mL | Ampoule 1 mL; carton 10 ampoules | Development record |
| Dexamethasone InjectionLP-182 | InjectionMedicine | 4 mg/mL | Ampoule 1 mL / 2 mL; carton 10 ampoules | Development record |
| Dextrose InjectionLP-183 | InjectionMedicine | 5% 500 mL IV infusion; 10% 500 mL IV infusion; 50% 50 mL ampoule | IV bottle/bag or ampoule | Development record |
| Diazepam InjectionLP-184 | InjectionMedicine | 5 mg/mL | Ampoule 2 mL; carton 10 ampoules | Development record |
| Furosemide InjectionLP-185 | InjectionMedicine | 10 mg/mL | Ampoule 2 mL; carton 10 ampoules | Development record |
| Gentamicin InjectionLP-186 | InjectionMedicine | 40 mg/mL (80 mg per 2 mL ampoule) | Ampoule 2 mL; carton 10 ampoules | Development record |
| Haloperidol InjectionLP-187 | InjectionMedicine | 5 mg/mL | Ampoule 1 mL; carton 10 ampoules | Development record |
| Heparin sodium InjectionLP-188 | InjectionMedicine | 5,000 IU/mL (25,000 IU per 5 mL vial) | Vial; carton 10 vials | Development record |
| Hydrocortisone Powder for injectionLP-189 | Powder for injectionMedicine | 100 mg vial | Vial; carton 10 vials | Development record |
| Hyoscine butylbromide InjectionLP-190 | InjectionMedicine | 20 mg/mL | Ampoule 1 mL; carton 10 ampoules | Development record |
| Insulin 30/70 InjectionLP-191 | InjectionMedicine | 100 IU/mL — 30% soluble human insulin with 70% isophane (NPH) human insulin; vial or cartridge | 10 mL vial or 3 mL cartridge; cold-chain carton | Development record |
| Insulin NPH InjectionLP-192 | InjectionMedicine | 100 IU/mL vial | 10 mL vial; cold-chain carton | Development record |
| Insulin soluble InjectionLP-193 | InjectionMedicine | 100 IU/mL vial | 10 mL vial; cold-chain carton | Development record |
| Lidocaine InjectionLP-194 | InjectionMedicine | 1%; 2% | Ampoule 2 mL / 5 mL / 10 mL | Development record |
| Magnesium sulfate InjectionLP-195 | InjectionMedicine | 500 mg/mL | Ampoule 10 mL; carton 10 ampoules | Development record |
| Metoclopramide InjectionLP-196 | InjectionMedicine | 5 mg/mL | Ampoule 2 mL; carton 10 ampoules | Development record |
| Ondansetron InjectionLP-197 | InjectionMedicine | 2 mg/mL | Ampoule 2 mL / 4 mL; carton 10 ampoules | Development record |
| Oxytocin InjectionLP-198 | InjectionMedicine | 10 IU/mL | Ampoule 1 mL; cold-chain carton | Development record |
| Phenytoin InjectionLP-199 | InjectionMedicine | 50 mg/mL | Ampoule 5 mL; carton 10 ampoules | Development record |
| Potassium chloride InjectionLP-200 | InjectionMedicine | 2 mEq/mL | Ampoule 10 mL; hospital use only | Development record |
| Sodium bicarbonate InjectionLP-201 | InjectionMedicine | 8.4% | Ampoule 10 mL / 20 mL | Development record |
| Sodium chloride InjectionLP-202 | InjectionMedicine | 0.9% 10 mL ampoule; 0.9% 500 mL IV infusion | Ampoule or IV bottle/bag | Development record |
| Thiamine (Vitamin B1) InjectionLP-203 | InjectionMedicine | 100 mg/mL | Ampoule 1 mL; carton 10 ampoules | Development record |
| Tranexamic acid InjectionLP-204 | InjectionMedicine | 100 mg/mL | Ampoule 5 mL; carton 10 ampoules | Development record |
| Vitamin K1 InjectionLP-205 | InjectionMedicine | 10 mg/mL | Ampoule 1 mL; carton 10 ampoules | Development record |
| Water for injection InjectionLP-206 | InjectionMedicine | 5 mL ampoule; 10 mL ampoule; 20 mL ampoule | Ampoule; carton 100 ampoules | Development record |
No matching record.
Try a broader generic name, another presentation or a portfolio reference.
Professional enquiries
Enquire about this product category.
Include the generic name or portfolio reference, your organisation and destination country.